Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR03U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,713
Award facts
- Contract value 100% obligated
- $32,713.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,713.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 mL syringes with a completion date of December 16, 2025. This non-set-aside competitive award represents a single delivery order fulfillment of the biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains extensive contracts with the DLA to supply medications and medical supplies to military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC enables the company to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs globally, serving customers including the Defense Health Agency and the U.S. Coast Guard. The award demonstrates AmerisourceBergen's established capability to meet competitive federal procurement requirements for specialized pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FR03U?
SPE2DR26FR03U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FR03U worth?
The government has obligated $32,713 on SPE2DR26FR03U.
Is contract SPE2DR26FR03U an order under another contract?
Yes. SPE2DR26FR03U is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR03U competed?
The extent of competition for SPE2DR26FR03U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award